Invention Grant
- Patent Title: Imidazo-fused heterocycles and uses thereof
-
Application No.: US17071273Application Date: 2020-10-15
-
Publication No.: US11858938B2Publication Date: 2024-01-02
- Inventor: Lin Zhi
- Applicant: Ligand Pharmaceuticals Incorporated
- Applicant Address: US CA San Diego
- Assignee: Ligand Pharmaceuticals, Inc.
- Current Assignee: Ligand Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Knobbe, Martens, Olson & Bear, LLP
- The original application number of the division: US15070718 2016.03.15
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
Compounds and methods in the fields of chemistry and medicine are disclosed. Some of the disclosed embodiments include compounds, compositions and methods of using imidazole-fused heterocycle amines. Some of the disclosed embodiments include imidazo-fused heterocycle compounds useful to treat leukemia and other hematopoietic disorders.
Public/Granted literature
- US20210040102A1 IMIDAZO-FUSED HETEROCYCLES AND USES THEREOF Public/Granted day:2021-02-11
Information query
